1. Home
  2. ACOG vs ASMB Comparison

ACOG vs ASMB Comparison

Compare ACOG & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • ASMB
  • Stock Information
  • Founded
  • ACOG 2000
  • ASMB 2005
  • Country
  • ACOG Canada
  • ASMB United States
  • Employees
  • ACOG N/A
  • ASMB N/A
  • Industry
  • ACOG
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACOG
  • ASMB Health Care
  • Exchange
  • ACOG Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • ACOG 91.6M
  • ASMB 84.5M
  • IPO Year
  • ACOG N/A
  • ASMB 2010
  • Fundamental
  • Price
  • ACOG $5.88
  • ASMB $13.30
  • Analyst Decision
  • ACOG
  • ASMB Buy
  • Analyst Count
  • ACOG 0
  • ASMB 2
  • Target Price
  • ACOG N/A
  • ASMB $35.00
  • AVG Volume (30 Days)
  • ACOG 122.5K
  • ASMB 22.6K
  • Earning Date
  • ACOG 11-15-2024
  • ASMB 03-27-2025
  • Dividend Yield
  • ACOG N/A
  • ASMB N/A
  • EPS Growth
  • ACOG N/A
  • ASMB N/A
  • EPS
  • ACOG N/A
  • ASMB N/A
  • Revenue
  • ACOG N/A
  • ASMB $28,326,000.00
  • Revenue This Year
  • ACOG N/A
  • ASMB $282.16
  • Revenue Next Year
  • ACOG N/A
  • ASMB N/A
  • P/E Ratio
  • ACOG N/A
  • ASMB N/A
  • Revenue Growth
  • ACOG N/A
  • ASMB N/A
  • 52 Week Low
  • ACOG $4.66
  • ASMB $11.01
  • 52 Week High
  • ACOG $7.00
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • ASMB 38.89
  • Support Level
  • ACOG N/A
  • ASMB $13.13
  • Resistance Level
  • ACOG N/A
  • ASMB $14.25
  • Average True Range (ATR)
  • ACOG 0.00
  • ASMB 0.55
  • MACD
  • ACOG 0.00
  • ASMB -0.07
  • Stochastic Oscillator
  • ACOG 0.00
  • ASMB 15.38

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: